279 studies found for:    (North Carolina) [LOCATION-STATE] AND (prostate cancer) [CONDITION]
Show Display Options
Rank Status Study
1 Recruiting Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Castration-resistant Prostate Cancer
Intervention:
2 Active, not recruiting S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Multiple Myeloma;   Plasma Cell Neoplasm;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: assessment of therapy complications
3 Recruiting Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: LHRH agonist;   Procedure: surgery
4 Active, not recruiting Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: prednisone;   Drug: triptorelin;   Radiation: radiation therapy
5 Recruiting Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: radiation therapy;   Radiation: Whole-pelvic radiotherapy (WPRT)
6 Active, not recruiting Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
7 Active, not recruiting Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: flutamide;   Radiation: radiation therapy
8 Terminated Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: mitoxantrone;   Drug: prednisone
9 Completed External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: brachytherapy;   Radiation: iodine I 125;   Radiation: radiation therapy
10 Completed Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer
Conditions: Hot Flashes;   Prostate Cancer
Interventions: Dietary Supplement: soy isoflavones;   Dietary Supplement: soy protein isolate;   Drug: venlafaxine;   Drug: placebo
11 Completed Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Radiation: radiation therapy
12 Completed Brachytherapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: iodine I 125
13 Completed Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: 3D-CRT
14 Active, not recruiting Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET photon therapy
15 Active, not recruiting S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: atrasentan hydrochloride;   Drug: docetaxel;   Drug: prednisone;   Other: placebo
16 Recruiting Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone
17 Completed Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: exisulind
18 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
19 Completed Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
Conditions: Prostate Cancer;   Sexual Dysfunction
Interventions: Drug: tadalafil;   Other: placebo
20 Terminated S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: goserelin;   Drug: mitoxantrone hydrochloride;   Drug: prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years